TELMISARTAN 40mg. IP + HYDROCHLOROTHIAZIDE 12.5mg. IP

Belongs to the class of anti-hypertensive primarily taken for the reduction of high blood pressure. An effective and well-tolerated treatment option for patients with hypertension. (Sverre E Kjeldsen, 2010) Significantly more efficacious than telmisartan monotherapies in patients with mild to moderate hypertension. (Steen Neldam, 2014) Confers greater diastolic blood pressure and systolic blood pressure control compared with low-dose losartan 50 mg/ hydrochlorothiazide. (Yves Lacourcière, 2005) Provides significantly greater reductions in blood pressure in patients with hypertension. (Schmieder, 2004) An effective and well-tolerated in patients with mild-to-severe hypertension, including patients with cardiovascular risk factors such as advanced age, obesity, chronic kidney disease, diabetes mellitus, and treatment-resistant hypertension. (Sverre Kjeldsen, 2013) A suitable approach for difficult-to-treat patients with moderate to severe hypertension. (Sverre E. Kjeldsen MD, 2013)